Role of surgery in the multimodal treatment of primary and recurrent leiomyosarcoma of the inferior vena cava
Ferdinando Cananzi(Humanitas University), Vittorio Quagliuolo(Humanitas University), Piergiuseppe Colombo(Humanitas University), Maria Grazia Bordoni(Humanitas University), Chiara Mussi(University of Modena and Reggio Emilia), Andrea Marrari(IRCCS Humanitas Research Hospital), Rita De Sanctis(Humanitas University)
Cited by 33
Related Papers
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial
|The Lancet Oncology|2017|493
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial
|The Lancet Neurology|2021|260
Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with Cancer
|Cancer Discovery|2020|183
The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65 – 74 years and more than 75 years
|BMC Geriatrics|2018|179
Functional changes in Duchenne muscular dystrophy
|Neurology|2011|178